Selected
Type of publications
Regions
Countries
Diseases
Publication date
Target population
Available to download in languages
338 results found
2023 ∙ Eiden, Amanda L. Barratt, Jane Nyaku, Mawuli K.
A review of factors influencing vaccination policies and programs for older adults globally
  • Acceptance
  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Herpes zoster
  • Tetanus
Rating:
Not applicable
2023 ∙ Jagne, Isatou von Mollendorf, Claire Wee-Hee, Ashleigh Ortika, Belinda Satzke, Catherine Russell, Fiona M.
A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of age
  • Efficacy/effectiveness
  • Newborn
  • Children
  • Pneumococcal disease
Rating:
Low
2023 ∙ Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
  • Economic aspects
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Pneumococcal disease
  • Rotavirus
  • Human papillomavirus (HPV)
  • Meningococcal disease
  • Mumps
  • Measles
  • Rubella
Rating:
Not applicable
2023 ∙ Pichichero, Michael Malley, Richard Kaur, Ravinder Zagursky, Robert Anderson, Porter
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
  • Efficacy/effectiveness
  • Children
  • Adolescents
  • Pneumococcal disease
Rating:
Critically low
2023 ∙ Du, Yuanze Wang, Yi Zhang, Ting Li, Juanjuan Song, Hewei Wang, Yuanyuan Xu, Yifei Cui, Jingwen Yang, Ming Wang, Zengwu Wu, Xiuyun Wang, Chunping
Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review
  • Economic aspects
  • All age groups
  • Pneumococcal disease
Rating:
Not applicable
2023 ∙ Wannarong, T. Ekpatanaparnich, P. Boonyasiri, A. Supapueng, O. Vathanophas, V. Tanphaichitr, A. Ungkanont, K.
Efficacy of Pneumococcal Vaccine on Otitis Media: A Systematic Review and Meta-Analysis
  • Efficacy/effectiveness
  • Newborn
  • Children
  • Pneumococcal disease
Rating:
Low
2023 ∙ Patel, J. Noureldin, M. Fakhouri, D. Farraye, F. A. Kovar-Gough, I. Warren, B. Waljee, A. K. Piper, M. S.
Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
  • Coverage
  • Adults
  • Older adults
  • Pneumococcal disease
Rating:
Not applicable
2023 ∙ Tafuri, S. Cuscianna, E. Bianchi, F. P.
Prevalence of poliovirus neutralizing antibodies in Italian population: A systematic review and meta-analysis
  • Efficacy/effectiveness
  • All age groups
  • Italy
  • Poliomyelitis
Rating:
Critically low
2023 ∙ Ahmad, Hanis Sanef, Siti Aishah Shahabudin, Winda Zulaiha Mohtar, Norfaqihah Hassan, Mohd Rohaizat Jeffree, Mohammad Saffree Lukman, Khamisah Awang Ghazi, Hasanain Faisal Syed Abdul Rahim, Syed Sharizman
Socioecological Challenges of Polio Supplementary Immunization Activities (SIAs) in the Asia-Pacific Region: A Systematic Review
  • Coverage
  • Acceptance
  • All age groups
  • Parents/caregivers
  • Healthcare workers
  • Poliomyelitis
Rating:
Not applicable
2023 ∙ Reyburn, Rita Tsatsaronis, Anthea von Mollendorf, Claire Mulholland, Kim Russell, Fiona M. Duke T, Graham H. Graham S. Gray A. Gwee A. von Mollendorf C. Mulholland K. Russell F. Hume-Nixon M. Kazi S. Kevat P. Neal E. Nguyen C. Quach A. Reyburn R. Ryan K. Walker P. Wilkes C. Chua P. Nisar Y. B. Simon J. Were W. A. R. I. Review group
Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years old
  • Efficacy/effectiveness
  • Administration
  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
Rating:
Critically low